Ab initio molecular orbital calculations (at the MP4/6-3lG(d,p) level using MP2/6-31G(d,p) geometries and ZPE corrections) on the cycloaddition of the model HC=P + HC=P system suggest that the head-to-head dimerization of phosphaalkyne giving 1,4-diphosphacyclobutadiene is inherently favored over the head-to-tail approach yielding 1,3-diphosphacyclobutadiene (by 37 kJ/mol); thus the experimental observation of the latter can be understood by a steric effect of the bulky substituents employed or a catalytic effect of metal fragments. Both dimers undergo, however, further reactions giving the most stable structure, diphosphabicyclo [1.1.0] butane. The latter molecule, also trapped by metal fragments, is likely to be an intermediate of the thermal tetramerization of HCP, leading to tetraphosphacubane.
Ab initio quantum chemical calculations have been used to about 180 kJ/mol high. Electron density is largely delocalized within the three-membered P 3 ring not only in explore the P 3 H 3 potential energy surface focussing on the ring-chain rearrangements of the three-membered ring in the C 3v -symmetric 1b (all-cis) but also in 1a (C s ). The proton affinity of 1a is similar to that of PH 3 . The proton affinities (PH) 3 (1), the parent triphosphirane. Relative energies between stationary points were estimated using the decrease with n in cyclo-(CH 3 ) 3 -n (PH) n and their values were obtained: PA(1a) = 777 ±10, PA(diphosphirane) = 799 QCISD(T)/6-311G(d,p) method based on MP2/6-31G(d,p) geometries and corrected for zero-point contributions. Ring ±10 and PA(phosphirane) = 802 ±10 kJ/mol. Heats of formation are evaluated as follows (∆H°f 0 at 0 K in kJ/mol): strain, proton affinities, ionization and excitation energies and heats of formation have been evaluated using larger 1a, 70 ±10; cyclo-(PH) 2 (PH 2 ) + (protonated 1a), 821 ±10; diphosphirane, 85 ±10; cyclo-(CH 2 )(PH)(PH 2 ) + (protonated basis sets, e.g. 6-311++G(3df,2p). The cyclic transtriphosphirane (1a) is the most stable P 3 H 3 isomer and lies diphosphirane), 814 ±10; phosphirane, 86 ±10; and protonated phosphirane, 812 ±10 kJ/mol. All P rings remain about 40 kJ/mol below the open-chain phosphanyldiphosphene (H 2 P-P=PH). The decrease of ring strain in threecyclic following ionization to the radical cations. Adiabatic ionization energies (IE a ) are estimated as: 1a and membered rings when CH 2 is replaced by PH is confirmed. Triphosphirane 1a is a virtually strain-free ring and even diphosphirane, 9.3 ±0.3 eV and phosphirane 9.5 ±0.3 eV. The first UV absorption band shifts toward the longer wavelength gains some stabilization relative to three separate P-P single bonds. The reduced ring strain also helps diminish the region on going from phosphirane to 1a. The GIAO/B3LYP computed magnetic shieldings for 1a and related molecules phosphorus inversion barrier to 224 kJ/mol compared to the monocyclic isomers of (CH 2 )(PH) 2 and (CH 2 ) 2 (PH). reveal a clear relationship between the narrow bond angles in the rings and their unusually strong magnetic shielding. Compound 1a follows a pure ring-opening or a 1,2-hydrogen shift rather than a combined motion pathway, in fundamentalThe similarity of the predicted 31 P-NMR signals in 1a and its heteroanalog diphosphirane, (CH 2 )(PH) 2 , can be rationalized contrast with corresponding processes of diphosphirane and phosphirane. This is due to the existence of an open-chain in terms of a compensation of the carbon-substituent effect (downfield shift) and the bond-bending effect imposed by the P 3 H 3 phosphorane intermediate stabilized by allylic conjugation. The pericyclic ring-opening of 1a is the most ring (upfield shift). favored process but the energy barrier in the gas phase is eral, the existence of polyphosphorus compounds as rings
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.